Cargando…
Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
It has been speculated that some drugs can be used against SARS-CoV-2. As for antiretrovirals, the follow-up of pre-exposure prophylaxis (PrEP) users during the coronavirus disease 2019 (COVID-19) outbreak may help to understand the potential protective effect of PrEP against SARS-CoV-2. We aimed to...
Autores principales: | Fernandes, Danilo Euclides, Ferreira, Paulo Roberto Abrão, Mastroianni Kirsztajn, Gianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556904/ https://www.ncbi.nlm.nih.gov/pubmed/32981567 http://dx.doi.org/10.1017/S0950268820002253 |
Ejemplares similares
-
Patterns of Pre-exposure Prophylaxis (PrEP) Use in a Population Accessing PrEP in Jackson, Mississippi
por: Chase, Erin, et al.
Publicado: (2022) -
Utilizing emergency departments for pre‐exposure prophylaxis (PrEP)
por: Shull, Jordan A., et al.
Publicado: (2020) -
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
por: Nozza, Silvia, et al.
Publicado: (2022) -
Perceptions, motivations, and beliefs about HIV risk and pre-exposure prophylaxis (PrEP) among participants in a nurse-led PrEP service (PrEP-RN)
por: Orser, Lauren, et al.
Publicado: (2022) -
Perspectives of women prescribed HIV pre-exposure prophylaxis (PrEP)
por: Park, Connie, et al.
Publicado: (2017)